A detailed history of Truvestments Capital LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 104 shares of VKTX stock, worth $5,469. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104
Holding current value
$5,469
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$49.84 - $70.47 $5,183 - $7,328
104 New
104 $6,000
Q3 2019

Oct 10, 2019

SELL
$6.55 - $8.6 $6,550 - $8,600
-1,000 Closed
0 $0
Q2 2019

Jul 15, 2019

BUY
$7.67 - $10.63 $7,670 - $10,630
1,000 New
1,000 $8,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.03B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.